The COVID-19 Reality: An Update
10/03/22 • 29 min
Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section).
The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack.
We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable[1].
Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments
00:00 - Introductions
03:38 - Is COVID-19 Still a Thing?
10:55 - The GameChanger: Bivalent Booster
17:15 - The Different Boosters
19:40 - Applying to Practice: Dosing
22:48 - Pediatric Considerations
28:35 - Closing Thoughts
References and Resources
- 400 Americans are dying each day. We cannot accept this reality.
- Virtual Immunization Administration Training
- Get the CEimpact App
Host
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Guest
Katelyn Jetelina, MPH, PhD
Publisher, Your Local Epidemiologist
Subscribe to Katelyn's substack - Your Local Epidemiologist to receive a direct line of “translated” public health science to the local, national, and international community.
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of COVID-19 pandemic the United States
2. Describe the role of a bivalent vaccine for COVID-19
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-370-H-06-P
Initial release date: 10/3/2022
Expiration date: 10/3/2023
Additional CPE and CME details can be found here.
Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section).
The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack.
We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable[1].
Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments
00:00 - Introductions
03:38 - Is COVID-19 Still a Thing?
10:55 - The GameChanger: Bivalent Booster
17:15 - The Different Boosters
19:40 - Applying to Practice: Dosing
22:48 - Pediatric Considerations
28:35 - Closing Thoughts
References and Resources
- 400 Americans are dying each day. We cannot accept this reality.
- Virtual Immunization Administration Training
- Get the CEimpact App
Host
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Guest
Katelyn Jetelina, MPH, PhD
Publisher, Your Local Epidemiologist
Subscribe to Katelyn's substack - Your Local Epidemiologist to receive a direct line of “translated” public health science to the local, national, and international community.
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of COVID-19 pandemic the United States
2. Describe the role of a bivalent vaccine for COVID-19
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-370-H-06-P
Initial release date: 10/3/2022
Expiration date: 10/3/2023
Additional CPE and CME details can be found here.
Previous Episode
A Treatment for Monkeypox?
Monkeypox is the newest worldwide pandemic and closely mirrors both COVID-19 and HIV pandemics. A large difference is theoretical vaccines and treatments for monkeypox already exist. In this episode of GameChangers, host Geoff Wall, evaluates tecovirimat, a potential monkeypox treatment and the regulations that made it possible.
The GameChanger
Little to no randomized controlled data exist on tecovirimat’s safety and efficacy in monkeypox. A recent case series helps establish the safety of tecovirimat for monkeypox use.
Show Segments
00:00 - Introductions
02:40 - Current Issue of Monkeypox
04:02 - Tecovirimat “Animal Rule”
11:19 - The GameChanger: Tecovirimat Case Series
17:20 - Applying to Practice
20:45 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and resources:
- Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
- Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
Redeem your CPE or CME credit
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Continuing Education Information:
Learning Objectives:
1. Describe the development and use of tecovirimat under the “Animal Rule”
2. Discuss the latest report of tecovirimat use in US patients with monkeypox
All relevant financial relationships have been mitigated.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-354-H01-P
Initial release date: 09/26/22
Expiration date: 09/26/2023
Additional CPE & CME details can be found here
Next Episode
Restrictive versus Standard Fluids in Septic Shock
The current standard of care is to provide a bolus of 30 mL per kg of isotonic fluid for patients with septic shock. Recent retrospective studies question this practice. Join host, Geoff Wall, as he reviewed a NEJM article on the role of fluids in septic shock.
The GameChanger
Large boluses of fluid during septic shock may have unintended adverse events. Some data show that an approach with restrictive fluids may have no difference in death or adverse outcomes.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments
00:00 - Introductions
01:38 - Background on Septic Shock and Current Treatment
04:47 - Meyhoff et al Study
15:17 - Gamechanger: Study Findings
22:51 - Connecting to Practice
23:57 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and Resources
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Critique the Meyhoff et al study evaluating restrictive fluids in septic shock
2. Discuss current approaches to fluid resuscitation in patients with septic shock
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-371-H01-P
Initial release date: 10/10/2022
Expiration date: 10/10/2023
Additional CPE and CME details can be found here.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/ceimpact-podcast-385948/the-covid-19-reality-an-update-54918407"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to the covid-19 reality: an update on goodpods" style="width: 225px" /> </a>
Copy